-- Ionis Pharmaceuticals (IONS) has an average rating of overweight and mean price target of $105.45, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Price: $75.25, Change: $+0.42, Percent Change: +0.55%
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target by $25 to $375, based on a 2027 P/E of 9.0x, a modest discount to LAD's 10-year forward P/E of 10.3x. We reduce our adjusted EPS estimates to $35.30 from $39.25 for '26 and to $41.80 from $43.20 for '27. Following LAD's Q1 earnings beat, we are lowering our estimates and price target but reiterating our Strong Buy on the shares. LAD remains our top pick in auto retail, as the company continues to outperform in a more challenging environment for dealerships. LAD's same-store-sales growth is outperforming peers by a wide margin and its combination of aggressive share repurchases and accretive acquisitions is helping support its bottom line. Impressively, LAD bought back ~4% of total outstanding shares in Q1 after retiring 11% of its share count in 2025. We find LAD's current risk/reward compelling with significant upside potential in a more favorable demand environment, continuing to view the long-term growth story as intact and noting management's history of solid execution.
Stifel Canada on Thursday maintained its buy rating on the shares of Kinross Gold (K.TO, KGC) and its C$65.00 price target following the company's first-quarter results."Kinross reported Q1/26 adjusted EPS of $0.71 vs. our $0.69 (consensus: $0.72) on attributable GEO production of 492.6Koz vs. our 489.8Koz (consensus: 481.8Koz) at attributable cost of sales of $1,380/GEO and AISC of $1,732/GEO which were in-line and within the FY26 guidance ranges ($1,360 +/- 5% and $1,730 +/- 5%, respectively). Adjusted Q1/26 EPS absorbed a $91Mln withholding-tax charge, of which $65Mln relates to taxes payable in future quarters tied to repatriation of Mauritania cash flows. Record Q1/26 attributable FCF of $837.5Mln implies FCF/GEO ex-WC of $2,656/GEO (+$1,034/GEO or +63.8% QoQ vs. +$722/oz or +17.4% in gold price). Kinross repurchased $250.1Mln in shares in Q1/26 (plus $50Mln in April) and reaffirmed its 40%-of-FCF return-of-capital target. We estimate approx. $1.3Bln for share buybacks in 2026 (vs. $0.6Bln in 2025) or 3.4% of shares outstanding (vs. 2.5% in 2025). Q1/26 total liquidity stood at $3.9Bln, including $2.2Bln of cash (+$443Mln QoQ)," analyst Ralph Profiti wrote.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $40.93, Change: $+0.07, Percent Change: +0.17%
ConocoPhillips (COP) on Thursday reported a decline over the year in Q1 2026 production, as total output slipped both on a reported and adjusted basis.The company said Q1 production averaged 2.309 million barrels of oil equivalent per day, down from 2.389 million boe/d from the same period a year earlier.Adjusted for acquisitions and dispositions, production fell by 14,000 boe/d, or about 1%, from Q1 2025.In the US Lower 48, production totaled 1.453 million boe/d in the quarter, down from the 1.462 million boe/d reported a year earlier.That included 698,000 boe/d from the Delaware Basin, 200,000 boe/d from the Midland Basin, 367,000 boe/d from the Eagle Ford and 183,000 boe/d from the Bakken.Looking ahead, the company said it is excluding Qatar from its Q2 production guidance due to uncertainty tied to the conflict in the Middle East.It expects Q2 production to range between 2.185 million boe/d and 2.215 million boe/d. For the full year, ConocoPhillips projected production of 2.295 million boe/d to 2.325 million boe/d.The outlook includes a 20,000 boe/d annual adjustment reflecting the exclusion of Qatar from Q2 guidance, as well as a 15,000 boe/d impact from higher royalty rates at Surmont driven by stronger oil prices.The company expects 2026 capital expenditures to come in between $12 billion and $12.5 billion, including additional activity in the Permian Basin.It said the spending range reflects ongoing uncertainty in the macroeconomic environment and the timing of capital projects tied to North Field East and North Field South in Qatar.Price: $127.25, Change: $-1.00, Percent Change: -0.78%